Wilson’s Disease

  • A. G. Bearn
  • H. G. Kunkel
Part of the Ergebnisse der Inneren Medizin und Kinderheilkunde book series (KINDERHEILK. NF, volume 7)

Zusammenfassung

During the past decade Wilson’s disease has become one of the most intensively studied neurological disorders. The current perfervid interest in this condition almost certainly stems from recent investigations on copper metabolism which have shed light on the pathogenesis of this otherwise esoteric and seemingly unimportant disease.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    André, M. J., and L. van Bogaert: L’hérédité dans la dégénérescence hepato-lenti-culaire et le problème des rapports intrinsiques de la pseudo-sclérose des Westphal-Strümpell et da la maladie de Wilson. La situation nosologique de F “abdominal-Wilson” de Kehrer au sein de la D.H.L. L’Encéphale89, 1 (1950).Google Scholar
  2. 2.
    André, M. J Des signes biologiques et des caractères chniques de la cirrhose wilsonsienne. Leur signification au point de vue de la Physiopathologie de la dégénérescence lenticulaire. (A propos de quatre obervations nouvelles). Rev. belge Sci. Med.17, 185 (1946)Google Scholar
  3. 3.
    Baker, A B., ed: Clinical neurology. Vol. 2, New York: Paul B. Hoeber 1955.Google Scholar
  4. 4.
    Barnes, S., and E. W. Hurst: Hepato-lenticular degeneration. Brain48, 279 (1925).CrossRefGoogle Scholar
  5. 5.
    Barnes, S., and E. W. Hurst A further note on hepato-lenticular degeneration. Brain49, 36 (1926).CrossRefGoogle Scholar
  6. 6.
    Barnes, S., and E. W. Hurst Hepato-lenticular degeneration; a final note. Brain52, 1 (1929).CrossRefGoogle Scholar
  7. 7.
    Bearn, A. G.: Genetic and biochemical aspects of Wilson’s disease. Amer. J. Med.15, 442 (1953).PubMedCrossRefGoogle Scholar
  8. Bearn, A. G and H. G. Kunkel: Biochemical abnormahties in Wilson’s disease. J. Clin. Invest.81, 616 (1952) (Abstr.).Google Scholar
  9. 9.
    Bearn, A. G and H. G. Kunkel Abnormahties of copper metabohsm in Wilson’s disease and their relationship to the aminoaciduria. J. C in. Livest.38, 400 (1954).CrossRefGoogle Scholar
  10. 10.
    Bearn, A. G and H. G. Kunkel Locahzation of Cu64 in serum fractions following oral administration: an alteration in Wilson’s disease. Proc. Soc. Exper. Biol. a. Med.85, 44 (1954).Google Scholar
  11. 10a.
    Bearn, A. G and H. G. Kunkel Metabohc studies in Wilson’s disease using Cu64. J. Labor, a. Clin. Med.45, 623 (1955).Google Scholar
  12. 11.
    Bearn, A. G The place of BAL in the therapy of Wilson’s disease. Amer. J.Med. (In press) (Abstr.).Google Scholar
  13. 12.
    Bearn, A. G.,T. F. , A. G. Ritterband, and A. B. Gutman: Renal clearance studies in Wilson’s disease. Federat. Proc. 15 (1956).Google Scholar
  14. 12a.
    Bickel, H.: Zur Biochemie der Wilsonschen Krankheit. Verh. dtsch. Ges. inn. Med.61, 402 (1955).Google Scholar
  15. 13.
    Bielschowsky, M., and J. Hallervorden: Symmetrische Einschmelzungsherde im Stirnhirn beim WiLSON-Pseudosklerosekomplex. J. of Psychol.42, 177 (1931).Google Scholar
  16. 14.
    Bishop, C., W. T. Zimdahl, and J. H. Talbott: Uric acid in two patients with Wilson’s disease (hapatolenticular degeneration). Proc. Soc. Exper. Biol. a. Med.86, 440 (1954).Google Scholar
  17. 15.
    Blaha, H., H. Gastager, H. Tschabitscher, and F. Wewalka: Die Aminoacidurie im Rahmen der Stoffwechselstörungen bei hepatolenticulären Erkrankungen (Morbus Wilson und Pseudosklerose). Wien. khn. Wschr. 1954, 915.Google Scholar
  18. 16.
    Boudin, G., G. Pepin, and Calatchi: Gas famihal de dégénérescence hépato-lenticulaire, troubles du métabohsme des acides aminés et du cuivre. Effects du traitement par le B.A.L. Revue neur.87, 271 (1952).Google Scholar
  19. 17.
    Brain, W. B.: Diseases of the nervous system, ed. 5, London: Oxford University Press 1956.Google Scholar
  20. 18.
    Brand, I., and I. Takats: Histochemische Untersuchung des Kayser-Fleischerschen Hornhautringes. Graefes Arch.151, 391 (1951).CrossRefGoogle Scholar
  21. 19.
    Bridgman, O., and F. S. Smyth: Progressive lenticular degeneration. J. Nerv. a. Ment. Dis.99, 534 (1944).CrossRefGoogle Scholar
  22. 20.
    Bush, J. A., J. P. Mahoney, H. Markowitz, C. J. Gubler, G. E. Cartwright and M. M. Wintrobe: Studies on copper metabohsm. XVI. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J. Chn. Invest.34, 1766 (1955).CrossRefGoogle Scholar
  23. 21.
    Cartwright, G. E., R. E. Hodges, C. J. Gubler, J. P. Mahoney, K. Daum, M. M. Wintrobe, and W. B. Bean: Studies ON Copper Metabohsm. XLLL. Hepatolenticular Degeneration. J. Chn. Invest.83, 1487 (1954)CrossRefGoogle Scholar
  24. 21a.
    Cartwright, G. E .,J. A. Bush, H. Markowitz, J. P. Mahoney, and C. J. Gubler: Further studies on the abnormahties in the metabohsm of copper in Wilson’s disease. J. Clin. Invest.34, 925 (1955).Google Scholar
  25. 22.
    Cassirer, R.: Ein Fall von progressiver Linsenkernerkrankung. Neurol. Zbl.32,1284 (1913).Google Scholar
  26. 23.
    Cooper, A. M., R. D. Eckhardt, W. W. Faloon, and C. S. Davidson: Investigation of the aminoaciduria in Wilson’s disease (hepatolenticular degeneration): demonstration of a defect in renal function. J. Clin. Invest.29, 265 (1950).PubMedCrossRefGoogle Scholar
  27. 24.
    Cumings, J. N., H. J. Goodwin, and C. J. Earl: Blood copper and its relationship to the globuhns. J. Clin. Path.8, 69 (1955).PubMedCrossRefGoogle Scholar
  28. 25.
    Cumings, J. N The copper and iron content of brain und hver in the normal and in hepato-lenticular degeneration. Brain71, 410 (1948).PubMedCrossRefGoogle Scholar
  29. 26.
    Cumings, J. N The effects of B.A.L. in hepatolenticular degeneration. Brain74, 10 (1951).PubMedCrossRefGoogle Scholar
  30. 27.
    Cumings, J. N Copper storage in hepatolenticular degeneration and allied diseases. Proc. Roy. Soc. Med.47, 152 (1954).PubMedGoogle Scholar
  31. 28.
    Denny-Brown, D.: Diseases of the basal gangha and subthalamic nuclei, vol 6, New York: Oxford University Press 1945.Google Scholar
  32. 29.
    Denny-Brown, D and H. Porter: The effect of BAL (2,3 dimercaptopropanol) in hepatolenticular degeneration (Wilson’s disease). New England J. Med.245, 917 (1951).CrossRefGoogle Scholar
  33. 30.
    Dent, C. E., and H. Harris: The genetics of “cystmuria”. Ann. Eugenics,16, 60 (1951).CrossRefGoogle Scholar
  34. 31.
    Earl, C. J., M. J. Moulton, and B. Selverstone: Metabolism of copper in Wilson’s disease and in normal subjects; studies with Cu64. Amer. J. Med.17, 205 (1954).PubMedCrossRefGoogle Scholar
  35. 32.
    Fleischer, B.: Zwei weitere Fälle von grünlicher Verfärbung der Kornea. Khn. Mbl. Augenheilk.41, 489 (1903).Google Scholar
  36. 33.
    Fleischer, B Die periphere braungrünliche Hornhautverfärbung als Symptom einer eigenartigen Allgemeinerkrankung. Münch, med. Wschr. 1909, 1120.Google Scholar
  37. 34.
    Fleischer, B Über eine der „Pseudosklerose” nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische Störungen, bräunliche Pigmentierung bestimmter Gewebe, insbesondere auch der Hornhautperipherie, Lebercirrhose). Dtsch. Z. Nerven-heilk.44, 179 (1912).CrossRefGoogle Scholar
  38. 35.
    Fleischer, B and W. Gerlach: Zur Frage der Silberpigmentierung des Kayser-Fleischerschen Hornhautringes. Klin. Wschr. 1934, 255.Google Scholar
  39. 36.
    Franklin, E. C., and A. Bauman: Liver dysfunction in hepatolenticular degeneration; a review of eleven cases. Amer. J. Med.15, 450 (1953).PubMedCrossRefGoogle Scholar
  40. 37.
    Freedberg, H.: Hepatolenticular degeneration (Wilson’s disease); report of one case with severe portal cirrhosis and splenomegaly. Ann. Int. Med.22, 418 (1945).Google Scholar
  41. 38.
    Frerich, F. T.: Klinik der Leberkrankheiten. 2. Band, S. 62. Braunschweig: Friedrich Vie weg u. Sohn 1861.Google Scholar
  42. 39.
    Froment, J., P. Bonnet, and R Masson: la Pseudosclérose Type Westphal-Strümpell. J. Med. (Lyon)16, 393 (1935) Google Scholar
  43. 40.
    Gabrod, A. E.: Inborn errors of metabolism, ed. 2, London: Henry Frowde and Hodder, Stoughton 1923.Google Scholar
  44. 41.
    Geblach, W., and R. Rohbschneideb: Besteht das Pigment des Kayseb-Fleischer-schen Homhautringes aus Silber ? Klin. Wschr. 1934, 48.Google Scholar
  45. 42.
    Glazebrook, A. J.: Wilson’s disease. Edinburgh Med. J.52, 83 (1945).Google Scholar
  46. 43.
    Gowers, W. R.: A manual of diseases of the nervous system. Vol. 2, p. 656, London: J. and A. Churchill 1888.Google Scholar
  47. 44.
    Gowers, W. R On tetanoid chorea and its association with cirrhosis of the hver. Rev. Neur. a. Psychiatr. 9, 249 (1906).Google Scholar
  48. 45.
    Greenfield, J. G.: Is hepatolenticular degeneration a clinico-pathological antity ? Proc. Roy. Soc. Med.47, 150 (1954).PubMedGoogle Scholar
  49. 46.
    Greenfield, J. G.,F. J. Poynton, and F. M. R. Walshe: On progressive lenticular degeneration (hepato-lenticular degeneration). Quart. J. Med.17, 385 (1924).Google Scholar
  50. 47.
    Hall, H. C.: La dégénérescence hepato-lenticulaire; maladie de Wilson, pseudosclérose. Paris: Masson et Cie. 1921.Google Scholar
  51. 48.
    Haurowitz, F.: Über eine Anomahe des Kupferstoffwechsels. Z. physiol. Chem.190, 72 (1930).CrossRefGoogle Scholar
  52. 49.
    Herz, E., and A. L. Drew Jr.: Hepatolenticular degeneration; analysis of dyskinetic phenomena; relation of degree of hepatic damage to course of the disease; nervous disorders in ordinary disease of the liver. Arch, of Neur.63, 843 (1950).Google Scholar
  53. 50.
    Hodges, R. E., W. M. Kirkendall, C. Schwartz, and J. B. Wild: Some aspects of kidney function in hepatolenticular degeneration (Wilson’s disease). J. Clin. Invest.33, 942 (1954).Google Scholar
  54. 51.
    Holmberg, C. G., and C. B. Laurell: Oxidase reactions in human plasma caused by ceruloplasmin. Scand. J. Clin. a. Labor. Invest. 3, 103 (1951).CrossRefGoogle Scholar
  55. 52.
    Holmberg, C. G., and C. B. Laurell :Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties. Acta chem. scand (Copenh.)2, 550 (1948).CrossRefGoogle Scholar
  56. 53.
    Homburger, F., and H. L. Kozol: Hepatolenticular degeneration. J. Amer. Med. Assoc.130, 6 (1936).CrossRefGoogle Scholar
  57. 54.
    Homen, E. A.: Eine eigentümhche Famihenkrankheit, unter der Form einer progressiven Dementia, mit besonderem anatomischen Befund. Neurol. Zbl.9, 514 (1890).Google Scholar
  58. 55.
    Hood, B., and S. E. Fagerberg: Hepato-lenticular degeneration. Biochemical observations in chüdren with and without neurological symptoms. Hjrperamino-aciduria. Acta med. scand. (Stockh.)140, 374 (1951).CrossRefGoogle Scholar
  59. 56.
    Hornbostel, H.: Neuere Erkenntnisse über das hepato-lentikuläre Syndrom. Schweiz, med. Wschr. 1954, 7.Google Scholar
  60. 57.
    Howard, C. P., and C. E. Royce: Progressive lenticular degeneration associated with cirrhosis of the liver (Wilson’s disease). Arch. Int. Med.24, 497 (1919).CrossRefGoogle Scholar
  61. 58.
    Jervis, G. A., J. Notkin, I. S. Freiman, and J. Moore: Progressive lenticular degeneration (Wilson’s disease). Psychiatr. Quart.16, 357 (1942).Google Scholar
  62. 59.
    Kayser, B.: Über einen Fall von angeborener griüüicher Verfärbung der Cornea. Klin. Mbl. Augenheük.40, 22 (1902).Google Scholar
  63. 60.
    Kehrer, F.: Zur Ätiologie und Nosologie der Pseudosklerose Westphal-Wilson. Z. Neur.129, 488 (1930).Google Scholar
  64. 61.
    Kjerrumgaard, E.: Case of ocular chalcosis. Acta ophthalm. (Copenh.)19, 261 (1941).CrossRefGoogle Scholar
  65. Knehr, C. a., and a. G. Bearn: (Data to be pubhshed).Google Scholar
  66. 63.
    Lehoczky, T.: Zur Anatonüe imd Klinik der wilson-Pseudosklerose Gruppe. Arch. f. Psychiatr.95, 481 (1931).CrossRefGoogle Scholar
  67. 64.
    Lhermitte, J., and W. S. Mxjncie: Hepatolenticular degeneration; a report of three unusual cases. Arch, of Neur.23, 750 (1930).Google Scholar
  68. 65.
    Lüthy, F.: Über die hepato-lentikuläre Degeneration (Wilson-Westphal-Strümpell). Dtsch. Z. Nervenheük.123, 101 (1931).CrossRefGoogle Scholar
  69. 66.
    Mahoney, J. P., A. A. Sandberg, C. J. Gubler, G. E. Cartwright, and M. M. Wintrobe: Uric acid metabohsm in hepatolenticular degeneration. Proc. Soc. Exper. Biol. A. Med.88, 427 (1955).Google Scholar
  70. 67.
    Mandelbrote, B. M., M. W. Stanier, R. H. S. Thompson, and M. N. Thurston: Studies on copper metabohsm in demyehnating diseases of the central nervous system. Bram71, 212 (1948).CrossRefGoogle Scholar
  71. 68.
    Markowitz, H., C. J. Gubler, J. P. Mahoney, G. E. Cartwright, and M. M. Wintrobe: Studies on copper metabohsm. XIV. Copper, coeruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular, degeneration and the nephrotic syndrome. J. Clin. Invest.34, 1498 (1955).PubMedCrossRefGoogle Scholar
  72. 69.
    Marston, H. R., and H. J. Lee: The effects of copper deficiency and of chronic overdosage with copper on Border-Leicester and Merino sheep. J. Agr. Sci.38, 229 (1948).CrossRefGoogle Scholar
  73. 70.
    Matthews, W. B.: The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson’s disease). J. of Neurol.17, 242 (1954).Google Scholar
  74. 71.
    Matthews, W. B.,M. D. Milne, and M. Bell: The metabohc disorder in hepato-lenticular degeneration Quart. J. Med.21, 425 (1952).Google Scholar
  75. 72.
    Newell, F. W., J. A. D. Cooper, and C. J. Farmer: Effect of BAL (2,3 dimercaptopropanol) on intraocular copper. Amer. J. Ophthalmol.32, 161 (1949).Google Scholar
  76. 73.
    Okinaka, S., M. Yoshekowa, M. Toyoda, T. Mozai. Y. Toyokuro, and M. Elamayama: Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson’s disease. A. M. A. Arch. Neurol, and Psychiat.72, 573 (1954).Google Scholar
  77. 74.
    Ormurod, J. A.: Cirrhosis of the liver in a boy, with obscure and fatal nervous symptoms St. Barth. Hosp. Rep.26, 57 (1890).Google Scholar
  78. 75.
    Peters, R. A., L.A.Stocken, and R. H. S. Thompson: British antilewisite (BAL). Nature (London)156, 616 (1945).CrossRefGoogle Scholar
  79. 76.
    Pierson, H.: Two types of Wilson’s disease; hepato-lenticular degeneration; case reports. J. of Neuropath.11, 19 (1952).CrossRefGoogle Scholar
  80. 77.
    Porter, H.: Amino acid excretion in degenerative diseases of the nervous system. J. Labor, a. Clin. Med.34, 1623 (1949).Google Scholar
  81. 78.
    Raskin, N., and J. M. Mackenzie: Hepatolenticular degeneration; clinical and pathological report of a case treated with BAL. J. Nerv. a. Ment. Dis.120, 176 (1954).Google Scholar
  82. 79.
    Richter, R.: The palhal component in hepato-lenticular degeneration. J. of Neuropath.7, 1 (1948).CrossRefGoogle Scholar
  83. 80.
    Rumpel, A.: Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierungen bei den damit verbundenen Fällen von Pseudosklerose, zugleich ein Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell). Dtsch. Z. Nervenheilk.49, 54 (1913).CrossRefGoogle Scholar
  84. 81.
    Rystedt, G.: Sur un cas de la maladie de Wilson. Acta med. scand. (Stockh.)59, 377 (1923).CrossRefGoogle Scholar
  85. 82.
    Scharenberg, K., and A. L. Drew Jr.: The histopathology of Wilson’s disease; a study with silver carbonate. J. of Neuropath.13, 181 (1954).CrossRefGoogle Scholar
  86. 83.
    Schaltenbrand, G.: Lehrbuch der Neurologie, I.Band: Die Nervenkrankheiten. Stuttgart: Georg Thieme 1951.Google Scholar
  87. 84.
    schechter, M. M., and C.A. Jones: Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy. Arch. Int. Med.91, 541 (1923).CrossRefGoogle Scholar
  88. 85.
    Scheinberg, I. H., and D. Gitlin: Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson’s disease). Science (Lancaster, Pa.)116, 484 (1952).Google Scholar
  89. 86.
    Schob: Zur pathologischen Anatomie der wilson-Pseudosklerose Gruppe. Dtsch. Z. Nervenheim.84, 145 (1925).CrossRefGoogle Scholar
  90. 87.
    Schrier, K.: Die angeborenen Störungen des Eiweißstoffwechsels. G. von Bergmann, W. Frey and H. Schwiegk, eds., Handbuch der inneren Medizin, 4 Aufl., 7. Band. Berlin-Göttingen-Heidelberg: Springer-Verlag 1954.Google Scholar
  91. 88.
    Siemerling, E., and H. Oloff: Pseudosklerose (Westphal-Strümpell) mit Corneal-ring (Kayser-Fleischer) und doppelseitiger Scheinkatarakt, die nur bei seithcher Beleuchtung sichtbar ist und die der nach Verletzung durch Kupfersplitter entstehenden Katarakt ähnhch ist. Khn. Wschr. 1922, 1087.Google Scholar
  92. 89.
    Sjövall, E., and A. Wallgren: Some aspects of hepatolenticular degeneration and its pathogenesis. Acta psychiatr. (Copenh.)9, 435 (1934).CrossRefGoogle Scholar
  93. 90.
    Spillane, J. D., J. W. Keyser, and R. A. Parker: Ammo-aciduria and copper metabohsm in hepatolenticular degeneration. J. Chn. Path.5, 16 (1952).CrossRefGoogle Scholar
  94. 91.
    Spiller, W. G.: The family form of pseudo-sclerosis and other conditions attributed to the lenticular nucleus. J. Nerv. a. Ment. Dis.48, 23 (1916).CrossRefGoogle Scholar
  95. 92.
    Stadler, H.: Die Erkrankungen der westphal-Wilsonschen Pseudosklerose auf Grund anatomischer, klinischer und erbbiologischer Untersuchungen. Z. Neur.164, 583 (1939).Google Scholar
  96. 93.
    Steger, J., and R. Steger: Die Störungen des Kupfer-und Aminosäuren-Stoffwechsels bei der hepato-cerebralen Degeneration und deren Behandlung mit BAL. Dtsch. Z. Nervenheük.172, 321 (1954).Google Scholar
  97. 94.
    Stein, W. H., A. G. Bearn and S. Moore: The amino acid content of the blood and urine in Wilson’s disease. J. Clin. Invest.88, 410 (1954).CrossRefGoogle Scholar
  98. 95.
    Stokes, J. B., A. B. Beck, D. H. Curnow, J. G. Topliss, and E. G. Saint: Aspects of copper metabohsm in Wilson’s disease. Australasian Ann. Med.4, 36 (1955).Google Scholar
  99. 96.
    Streifler, M., and S. Feldman: Effect of dimercaprol (BAL) in hepatolenticular degeneration. Arch, of Neur.69, 84 (1953).Google Scholar
  100. 97.
    Strümpell, A.: Über die Westphalsche Pseudosklerose und über diffuse Hirnsklerose, insbesondere bei Kindern. Dtsch. Z. Nervenheilk.12, 115 (1898).CrossRefGoogle Scholar
  101. 98.
    Strümpell, A Ein weiterer Beitrag zur Kenntnis der sog. Pseudosklerose. Dtsch. Z. Nervenheilk.14, 348 (1899).CrossRefGoogle Scholar
  102. 99.
    Sullivan, F. L., H. L. Martin, F. McDowell: Wilson’s disease (hepatolenticular degeneration); a famüy study. Arch, of Neur.69, 756 (1953).Google Scholar
  103. 100.
    Tobel, F.: Über Methionin-Cholinbehandlung der Pseudosklerose. Nervenarzt22, 30 (1951).PubMedGoogle Scholar
  104. 101.
    Thomalla, C.: Ein Faü von Torsionsspasmus mit Sektionsbefund und seine Beziehungen zur Athetose double, Wilsonschen &ankheit und Pseudosklerose. Z. Neur.41, 311 (1918).Google Scholar
  105. 102.
    Thomas, J. J.: A report of 3 cases of chronic progressive lenticular degeneration with mental deterioration. J. Nerv. a. Ment. Dis.46, 321 (1917).CrossRefGoogle Scholar
  106. 103.
    Thompson, R. H. S., and D. Watson: Serum copper levels in pregnancy and in preeclampsia. J. Clin. Path.2, 193 (1949).CrossRefGoogle Scholar
  107. 104.
    Turpin, R., H. Jerome, and H. Schmitt: Study of variations of the ceruloplasmin by an easy technique. Proc. Roy. Soc. Med.46, 1061 (1943).Google Scholar
  108. 105.
    Uzman, L., and D. Denny-Brown: Amino-aciduria in hepato-lenticular degeneration (Wilson’s disease) Amer. J. Med. Sci.215, 599 (1948).CrossRefGoogle Scholar
  109. 106.
    Uzman, L :On the relationship of Urinary copper excretion to the aminoacidmia in Wilson’s disease (hepatolenticular degeneration). Amer. J. Med. Sci.226, 645 (1953).PubMedCrossRefGoogle Scholar
  110. 107.
    Uzman, L :The familial nature of the amino-aciduria of Wilson’s disease (Hepatolenticular Degeneration). Amer. J. Med. Sci.223, 392 (1952).PubMedCrossRefGoogle Scholar
  111. 107a.
    Uzman, L., F.L. Iber, M. Knowlton and T.C. Chalmers: The mechanism of copper deposition in the liver in hepatolenticular degeneration. Amer. J. Med. 1956 (in press).Google Scholar
  112. 108.
    Verdier, de C.-H.: Paper Chromatograph analysis of amino-acid excretion in Wilson’s disease. Acta med. scand. (Stockh.)138, 344 (1950).CrossRefGoogle Scholar
  113. 109.
    Vogt, A.: Untersuchungen über das Substrat des Descemetipigmentringes bei Pseudosklerose. Khn. Mbl. Augenheilk.82, 433 (1929).Google Scholar
  114. 110.
    lsch, M.: Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell) Dtsch. Z. Nervenheilk.42, 335 (1911).CrossRefGoogle Scholar
  115. 111.
    Waggoner, R. W., and N. Malamud: Wilson’s disease in the light of cerebral changes foUowing ordinary acquired liver disorders. J. Nerv. a. Ment. Dis.96, 410 (1942).CrossRefGoogle Scholar
  116. 112.
    Walshe, J. M.: Wilson’s disease; new oral therapy. Lancet 1956, 25.Google Scholar
  117. 113.
    Warnock, C. G., and D. W. Neill: Dimercaprol in the pre-neurological stage of Wilson’s disease (hepatolenticular degeneration) J. of Neur.17, 70 (1954).Google Scholar
  118. 114.
    Westphal, C.: Über eine dem Bilde der cerebrospinalen grauen Degeneration ähnliche Erkrankung des centralen Nervensystems ohne anatomischen Befund, nebst einigen Bemerkungen über paradoxe Contraction. Arch. f. Psychiatr.14, 87 (1883).CrossRefGoogle Scholar
  119. 115.
    Wilson, S. A. K.: Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain34, 295 (1912).CrossRefGoogle Scholar
  120. 116.
    Wintrobe, M. M., G. E. Cartwright, R. E. Hodges, C. J. Gubler, J. P. Mahoney, K. Daum, and W. B. Bean: Copper Metabolism in Wilson’s disease. Trans. Assoc. Amer. Physicians67, 232 (1954)Google Scholar
  121. 117.
    Wintrobe, M. M., G. E. Cartwright, R. E. Hodges and C. J. Gubler: Studies on the function and metabolism of copper. J. Nutrit.50, 395 (1953).PubMedGoogle Scholar
  122. 118.
    Wollaeger, E. E., and H. C. Shands: Hepatolenticular degeneration; report of two cases with predominantly hepatogenic symptoms, one associated with Cruveilhier-Baumgarten syndrome. Arch. Int Med.75, 151 (1945).CrossRefGoogle Scholar
  123. 119.
    Wolff, H. P., N. Lang, and M. Knedel: Untersuchungen mit Cu64 über die Bindung des Kupfers an Serumeiweißkörper. Z. exper. Med.125, 359 (1955).CrossRefGoogle Scholar
  124. 120.
    Zimdahl, W. T., I. Hyman, and W. F. Stafford Jr.: The effect of drugs upon the copper metabohsm in hepatolenticular degeneration and in normal subjects. J. Labor, a. Clin. Med.43, 774 (1954).Google Scholar
  125. 121.
    Zimdahl, W. T., I. Hyman and E. D. Cook: Metabohsm of copper in hepatolenticular degeneration. Neurology3, 569 (1952).Google Scholar

Copyright information

© Springer-Verlag OHG. Berlin · Göttingen · Heidelberg 1956

Authors and Affiliations

  • A. G. Bearn
    • 1
  • H. G. Kunkel
    • 1
  1. 1.The Rockefeller Institute for Medical ResearchNew YorkUSA

Personalised recommendations